CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer

miR-193b Regulates Mcl-1 in Melanoma

(2011) Jiamin Chen et al.   AMERICAN JOURNAL OF PATHOLOGY

Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer

(2011) JI WOONG SON et al.   RESPIROLOGY

TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion

(2010) Y Wu et al.   BRITISH JOURNAL OF CANCER

New horizons in the treatment of cystic fibrosis

(2010) AW Cuthbert   BRITISH JOURNAL OF PHARMACOLOGY

Obesity adversely affects survival in pancreatic cancer patients

(2010) Robert R. McWilliams et al.   CANCER

UPA and PAI-1 Analysis from Fixed Tissues – New Perspectives for a Known Set of Predictive Markers

(2010) K. Malinowsky et al.   CURRENT MEDICINAL CHEMISTRY

MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells

(2010) Chengwang Xu et al.   EUROPEAN JOURNAL OF CANCER

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer

(2010) Hanna E. Rauhala et al.   INTERNATIONAL JOURNAL OF CANCER

Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk

(2010) Yafei Li et al.   LUNG CANCER

Global Methylation Pattern of Genes in Androgen-Sensitive and Androgen-Independent Prostate Cancer Cells

(2010) D. K. Mishra et al.   MOLECULAR CANCER THERAPEUTICS

Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma

(2009) Toyoki Moribe et al.   INTERNATIONAL JOURNAL OF CANCER

Regulation of cell signalling by uPAR

(2009) Harvey W. Smith et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer

(2009) X-F Li et al.   ONCOGENE

CFTR Is a Negative Regulator of NFκB Mediated Innate Immune Response

(2009) Neeraj Vij et al.   PLoS One

Selectivity of the NF- B Response

(2009) R. Sen et al.   Cold Spring Harbor Perspectives in Biology

The Nuclear Factor NF- B Pathway in Inflammation

(2009) T. Lawrence   Cold Spring Harbor Perspectives in Biology

Cystic Fibrosis Transmembrane Conductance Regulator Controls Lung Proteasomal Degradation and Nuclear Factor-κB Activity in Conditions of Oxidative Stress

(2008) Emilie Boncoeur et al.   AMERICAN JOURNAL OF PATHOLOGY

The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2

(2008) Manav Korpal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of urokinase-type plasminogen activator system in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

(2008) Masafumi Kumano et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: A case-control study in Chinese Han population

(2007) Di Qiao et al.   Journal of Cystic Fibrosis